Source: Emerald Health Therapeutics, Inc.
Emerald Health
Therapeutics Inc. (“Emerald” or the “Company”) (TSXV:EMH) (OTCQX:EMHTF)
has elected to exercise its right to accelerate the expiry of the $2.60
common share purchase warrants ("Warrants") issued by the Company
on April 20, 2017. Pursuant to the terms of the Warrants, the Company
may accelerate the expiry date of the Warrants when the closing sale
price of Emerald’s common shares on the TSX Venture Exchange is greater
than $3.50 per share for a period of 20 consecutive trading days and by
giving notice to the holders thereof.
As of
the market close on January 4, 2018, Emerald’s common shares had traded
above $3.50 for 20 consecutive trading days. Notice of the accelerated
Warrant expiry was provided to the holders of the 744,576 unexercised
Warrants effective January 5, 2018. The Warrants will now expire at 1:00
p.m. (Pacific time) on Monday, February 5, 2018. Any Warrants remaining
unexercised after this date will be cancelled.
About Emerald Health Therapeutics Inc.
Emerald
Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) operates through
Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary
and Licensed Producer under Canada’s Access to Cannabis for Medical
Purposes Regulations. Through Botanicals, Emerald is authorized to
produce and sell dried medical cannabis flower and medical cannabis oil.
It currently operates an indoor facility in Victoria, BC, and is
building a 500,000 s.f. greenhouse on 32 acres in Metro Vancouver, with
expansion potential to 1 million s.f. to serve the anticipated legal
Canadian adult-use cannabis market starting in 2018. Emerald also owns
50% of Pure Sunfarms, a partnership with Village Farms that is
converting an existing 1.1 million s.f. greenhouse in Delta, BC from
growing tomatoes to growing cannabis. Emerald’s team is highly
experienced in life sciences, product development and large-scale
agribusiness. Emerald is part of the Emerald Health group,
which is broadly focused on developing pharmaceutical, botanical and
nutraceutical products designed to provide wellness and medical benefits
by interacting with the human body’s endocannabinoid system.
Please visit www.emeraldhealth.ca for more information or contact:
No comments:
Post a Comment